AGRX
Agile Therapeutics, Inc
AGRX
AGRX
Delisted
AGRX was delisted on the 25th of March, 2024.
24 hedge funds and large institutions have $26.7M invested in Agile Therapeutics, Inc in 2019 Q2 according to their latest regulatory filings, with 1 funds opening new positions, 5 increasing their positions, 2 reducing their positions, and 3 closing their positions.
New
Increased
Maintained
Reduced
Closed
Holders
24
Holders Change
-2
Holders Change %
-7.69%
% of All Funds
0.52%
Holding in Top 10
1
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.02%
New
1
Increased
5
Reduced
2
Closed
3
Calls
$217K
Puts
–
Net Calls
+$217K
Net Calls Change
-$167K
Top Buyers
1 |
Vanguard Group
Malvern,
Pennsylvania
|
+$1.43M |
2 |
Renaissance Technologies
New York
|
+$175K |
3 |
![]()
JPMorgan Chase & Co
New York
|
+$102K |
4 |
BlackRock
New York
|
+$52.3K |
5 |
Acadian Asset Management
Boston,
Massachusetts
|
+$46.7K |
Top Sellers
1 |
PVI
Pura Vida Investments
New York
|
-$112K |
2 |
NIM
Needham Investment Management
New York
|
-$92.7K |
3 |
VF
Virtu Financial
New York
|
-$88K |
4 |
Royal Bank of Canada
Toronto,
Ontario, Canada
|
-$5.84K |
5 |
![]()
Simplex Trading
Chicago,
Illinois
|
-$1K |